Ziff Capital Partners leads Stellular Bio Series 1 financing

Health Care · United States · Undisclosed

Ziff Capital Partners led Stellular Bio's Series 1 financing round, joined by Cockrell Interests and other investors, to advance the company's lead candidate STLR-201 into clinical testing as a treatment for Sjogren's disease dry eye.